SCHEMBL23009504

SCHEMBL23009504

Cc1ccc(-c2cc(C(F)(F)F)c3c(N)c(C#N)sc3n2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.67
MAPT P10636 10/20 0.51
KDM4E B2RXH2 9/20 0.51
L3MBTL1 Q9Y468 8/20 0.51
KMT2A Q03164 7/20 0.51
MEN1 O00255 6/20 0.51
POLB P06746 3/20 0.51
USP2 O75604 2/20 0.51
TLR9 Q9NR96 2/20 0.51
CASP1 P29466 2/20 0.51
CASP7 P55210 2/20 0.51
HSD17B10 Q99714 2/20 0.51
ALOX15 P16050 1/20 0.51
RECQL P46063 1/20 0.51
BLM P54132 1/20 0.51
ALDH1A1 P00352 9/20 0.46
MAPK1 P28482 5/20 0.46
RXFP1 Q9HBX9 2/20 0.46
HPGD P15428 6/20 0.45
FOXM1 Q08050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23009512 0.89 LMNA (0.66) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009464 0.88 LMNA (0.64) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009520 0.88 LMNA (0.64) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009471 0.88 LMNA (0.64) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009516 0.88 LMNA (0.53) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009521 0.86 LMNA (0.62) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009518 0.84 LMNA (0.60) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009519 0.81 LMNA (0.67) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL23009511 0.78 KMT2A (0.54) LMNAMAPTKDM4EL3MBTL1KMT2A
SCHEMBL13568370 0.78 KDM4E (0.67) LMNAMAPTKDM4EL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021028919-A1 METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED BY BIOLOGICAL TARGETED CANCER DRUGS HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED (IL) 2021-02-18 WO disclosed